Left to right: Bashar Yafouz, Wagner H. Souza and Maryam Majedi

Medical Innovation Fellows pinch Proteus top spot

on May 15, 2020

Western Medical Innovation Fellows Bashar Yafouz, Wagner H. Souza, and Maryam Majedi participated in the fifth annual Proteus Innovation Competition and through their abstract, business plan proposal and business pitch grabbed one of the top three $5,000 prizes and the chance to license and market the technology.

The Fellows, part of Western’s Medical Innovation Fellowship (MIF) program which immerses early career scientists, engineers and clinicians in a training and research-heavy environment with the goal of developing future leaders and innovators of world-class medical technologies.

The skills learned from their program gave them a competitive advantage when they decided to participate in the Proteus Innovation Competition – an intense, four-month competition that takes three newly developed technologies from Ontario research institutions and challenges teams to plan their commercialization. It is a partnership among WORLDiscoveries, Western Entrepreneurship, Western Research Parks, TechAlliance, McMaster University and the University of Windsor.

Read more
ecommMedical Innovation Fellows pinch Proteus top spot

Master the Entrepreneur Skillset: A six-week virtual masterclass starting May 5th

on May 1, 2020

Becoming an entrepreneur takes a lot of ambition. The best time to start was yesterday. The next best time to start is May 5!

The ‘Master the Entrepreneur Skillset’ is a six-week online program that will introduce you to the tools and mindset required to succeed as an entrepreneur. You do not need an idea or a pre-existing team to join the program. Just an open mind and a willingness to learn and explore your full potential. For a limited time, our program is being offered for free to Western alumni, students, faculty, and staff (all tuition and fees waived). Space is limited. Sign-up today to claim your spot.

Read more
ecommMaster the Entrepreneur Skillset: A six-week virtual masterclass starting May 5th

COVID-19 Funding Opportunities

on April 15, 2020

Our team has compiled a list of funding opportunities to help combat the impacts of COVID-19. This list will be updated as opportunities become available.

Read more
ecommCOVID-19 Funding Opportunities

Western University: Growing The Ontario Economy

on October 29, 2019

The Ontario government has set up an Expert Panel on Intellectual Property with the mandate of the panel being to protect home-grown innovation and maximize commercialization. The panel is looking at various opportunities to improve in the post-secondary education sector including at incubators, accelerators, technology transfer offices, and innovation centres.

The panel is looking to make recommendations to the Ministry of Training, Colleges and Universities to improve the generation and commercialization of research and intellectual property.

Read more
ecommWestern University: Growing The Ontario Economy
Left to right: Ibrahim Marwa, MPH’16, Souzan Armstrong, Director of the Medical Innovation Fellowship, Bartosz Slak, Maryanne Siu, Mahmoud Ramin, and Jacob Reeves, PhD’18. The 2018-19 cohort of Western Medical Innovation Fellows received two BURST funds valued at 70k each to fund their new medical device startups.

Western Medical Innovation Fellows awarded two BURST funds

on April 16, 2019

The Western Medical Innovation Fellowship (MIF) immerses talented young scientists, engineers and clinicians in training and research environments that build innovation leaders and create novel medical technologies. Now at the end of their 10.5 month program, the 2018-19 Western Medical Innovation Fellows are looking to move onto their next adventure – entrepreneurship. As part of their program, the fellows consulted with clinicians across the local healthcare industry and developed two projects to address needs they discovered throughout the process that fit within their areas of expertise. These two projects are being spun-off into two London-based innovative medical startups thanks to the support of BURST, an incubation program for high-potential medical technology startups through the TechAlliance of Southwestern Ontario.

Read more
ecommWestern Medical Innovation Fellows awarded two BURST funds
FDA, Special to Western News, The U.S. Food and Drug Administration (FDA) recently approved the use of Azedra, a new compound developed by Progenics Pharmaceuticals Inc., for patients with rare tumours of the adrenal glands. Chemistry professor emeritus Duncan Hunter developed the compound with his Western lab team and applied for the patent 30 years ago.

Cancer drug earns FDA nod after decades

on August 7, 2018

Duncan Hunter chokes up a little when it is suggested that work he began at Western three decades ago will now, finally, be applied to saving hundreds of lives. “It’s a good thing,” said the Chemistry professor emeritus after a long pause. “It took 30 years and had its ups and downs. So, yes, it’s emotional.”

Last week, the U.S. Food and Drug Administration (FDA) approved the use of Azedra, a new compound developed by Progenics Pharmaceuticals Inc., for patients with rare tumours of the adrenal glands.

Read more
ecommCancer drug earns FDA nod after decades

IP 101 – The importance of laboratory notebooks

on December 21, 2017

A well-maintained laboratory notebook is an important tool for documenting experimental progress and keeping researchers organized. Maintaining a comprehensive laboratory notebook can also be a valuable resource when patenting a discovery. As discussed below, despite recent changes to the patent system in the United States, properly detailing experimental progress in lab notebooks remains relevant to the patent process and researchers would be well advised to be diligent in their record keeping.

Read more
ecommIP 101 – The importance of laboratory notebooks

IP 101 – Patent Infringement

on December 3, 2017

There is increasing pressure on Canadian universities to produce research with translational or commercial potential. In this regard, researchers typically work with the technology transfer offices at their university to identify technologies with commercial applicability and if appropriate, secure patent protection for such technologies. Rarely have academic institutions been concerned with infringing third party patents, assuming the nature of their work immunized them from such concerns. For the reasons discussed below, academic institutions may wish to pay greater attention to patent infringement issues and be mindful of using patented inventions in their research to avoid incurring potential legal liability as the shift towards commercial research continues.

Read more
ecommIP 101 – Patent Infringement

Moral rights – waived

on September 15, 2017

If you are an inventor who is looking for help from the University or other potential investors to commercialize your invention, you will likely come across an assignment agreement asking you to transfer ownership of the intellectual property rights associated with your invention in exchange for funding or marketing services.

However, upon reading such an agreement you may also notice that you are being asked to waive your “moral rights” to your invention under the Copyright Act. This may catch you off guard and question whether you are being asked to abandon your moral or ethical principles for the sake of marketing your invention.

Read more
ecommMoral rights – waived

Biologic is the beginning

on August 18, 2017

Biologics and its landscape in Canada: The pharmaceutical industry is currently a multi-billion dollar industry that continues to grow each year. In Canada, biologics (or biologic drugs) make up about 14% of drug spending at a cost of $3 billion a year. With the expiration of many key patents for top-selling biologics in recent years, the interest in producing ‘generic’ biologics (or “biosimilars”) has increased. Even if you are not concerned about inventing around existing patents, it may still be useful to know how biologics are classified by the Patent Office and the fact that the existence of biosimilars in the drug market significantly lowers the cost of these relatively expensive drugs.

Read more
ecommBiologic is the beginning